MXI1 and cancer: Noteworthy, a recently proposed model of MYC-dependent signal transfer from breast cancer cells to the surrounding cancer-associated fibroblasts involves exosome-transported miR-105, which downregulates the expression of MXI1, an inhibitor of MYC activity, and results in an increased MYC activity [56].